Trade GlaxoSmithKline PLC - GSKl CFD

Add to favourite

12.915

0.04%

0.290

Low: 12.915

High: 13.225

Market Trading Hours* (UTC) Opens on Tuesday at 07:00

Mon - Thu: 07:00 - 11:00 11:03 - 15:30

Summary
Historical Data

Trading сonditions

Spread

0.290

Long position overnight fee

-0.023263%

Short position overnight fee

0.001345%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

GBP

Margin

5.00%

Stock exchange

United Kingdom of Great Britain and Northern Ireland

Commission on trade

Key Stats

Prev. Close	12.92
Open	13.075
1-Year Change	-20.32%
Day's Range	12.915 - 13.225

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Apr 14, 2025	12.915	-0.050	-0.39%	12.965	13.260	12.915
Apr 11, 2025	12.920	0.140	1.10%	12.780	12.975	12.540
Apr 10, 2025	12.735	-0.495	-3.74%	13.230	13.335	12.695
Apr 9, 2025	12.595	-0.360	-2.78%	12.955	13.070	12.405
Apr 8, 2025	13.110	-0.245	-1.83%	13.355	13.595	13.025
Apr 7, 2025	13.290	-0.460	-3.35%	13.750	13.765	13.190
Apr 4, 2025	14.145	-0.420	-2.88%	14.565	14.670	14.060
Apr 3, 2025	14.580	0.160	1.11%	14.420	14.840	14.415
Apr 2, 2025	14.275	-0.100	-0.70%	14.375	14.465	14.120
Apr 1, 2025	14.445	-0.440	-2.96%	14.885	14.945	14.445
Mar 31, 2025	14.320	-0.235	-1.61%	14.555	14.800	14.320
Mar 28, 2025	14.815	0.090	0.61%	14.725	14.890	14.710
Mar 27, 2025	14.735	0.055	0.37%	14.680	14.775	14.630
Mar 26, 2025	14.720	-0.090	-0.61%	14.810	14.815	14.500
Mar 25, 2025	14.575	-0.235	-1.59%	14.810	15.100	14.575
Mar 24, 2025	14.550	-0.550	-3.64%	15.100	15.140	14.550
Mar 21, 2025	15.110	0.015	0.10%	15.095	15.270	15.020
Mar 20, 2025	15.045	0.020	0.13%	15.025	15.200	14.985
Mar 19, 2025	15.055	-0.105	-0.69%	15.160	15.185	14.850
Mar 18, 2025	15.305	0.095	0.62%	15.210	15.375	15.210

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

GSK Company profile

GlaxoSmithKline PLC - GSK CFD

GlaxoSmithKline (GSK) is a global healthcare company focussed in pharmaceuticals, vaccine development and consumer healthcare products.

The company began as an apothecary shop in London in 1715. Today, GlaxoSmithKline is headquartered in Brentford, England, with regional offices in the US and Singapore. GlaxoSmithKline’s primary listing is on the London Stock Exchange under the ticker symbol ‘GSK’. The GSK stock price in the form of American depositary shares is listed on the New York Stock Exchange.

GlaxoSmithKline’s pharmaceutical business covers a broad portfolio of medicines in respiratory, HIV, immuno-inflammation and oncology. The company has a leadership position in respiratory disease medicines. GlaxoSmithKline’s HIV business is managed through its unit ViiV Healthcare, with Pfizer and Shionogi as minority shareholders.

In addition to respiratory and HIV treatments, the company has a portfolio of pharmaceutical products for the treatment of conditions such as lupus, urology and anti-infectives.

Its Established Products Portfolio (EPP) includes mature medicines in the areas of anti-infectives, allergy, central nervous system, dermatology, respiratory and urology. These products are an important part of our Emerging Markets business.

GlaxoSmithKline is actively researching the World Health Organisation’s three priority diseases - HIV/AIDS, tuberculosis and malaria.

GlaxoSmithKline is also one of the world’s largest vaccine companies with a portfolio of more than 20 vaccines. The company has 12 vaccine manufacturing sites around the world. One of its four global R&D centres is dedicated to mRNA technology.

GlaxoSmithKline’s consumer healthcare business has portfolio of brands that include Sensodyne, Parodontax, Polident, Advil, Voltaire, Panadol, Striven, Theraflu and Centrum across oral health, pain relief, cold, flu and allergy, digestive health, and vitamins, mineral and supplements segments. GlaxoSmithKline is set to spin-off its consumer healthcare business into an independent company under the name ‘Haleon’.’

The company pays dividends on a quarterly basis, in July, October, January and April.
Follow the GlaxoSmithKline stock price live at Capital.com today.

Industry:

Pharmaceuticals (NEC)

980 Great West Road
BRENTFORD
MIDDLESEX TW8 9GS
GB

News

ECB interest-rate forecasts – Projections for the next five years

The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.

14:37, 10 April 2025

BlackRock shareholders: Who owns the most BLK stock?

BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.

13:46, 9 April 2025

Rendering of physical bitcoin tokens on black background

Bitcoin price predictions 2025–2050: third-party price target

We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.

10:28, 9 April 2025

Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target

Where will Tesla’s stock be in five years? Can the EV company keep its crown?

08:19, 9 April 2025

JasmyCoin price predictions 2025-2030: Third-party price target

How might JASMY behave in the future?

16:13, 8 April 2025

Signage outside the entrance of the Reserve Bank of Australia building in Sydney, Australia.

Australian interest-rate projections: where will rates be in 5 years?

As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.

21:37, 7 April 2025